Cardiolipin Ab IgA
Here’s what it reflects — and what to do about it.
Longetic pulls together every lab and record you’ve had, follows how Cardiolipin Ab IgA changes over time, and explains what’s shifting — so you walk into your next appointment prepared, with reminders for retests along the way.
What is Cardiolipin Ab IgA?
Antibodies targeting a membrane phospholipid, tested with IgG and IgM as part of the antiphospholipid antibody panel.
Cardiolipin is a phospholipid found in cell membranes, and antibodies against it are among the markers used to evaluate antiphospholipid syndrome, a condition associated with increased clotting risk and pregnancy complications. The IgA isotype is less routinely tested than IgG or IgM and its independent significance is still being studied, though it may be considered in people with strong clinical suspicion despite negative IgG and IgM results. This test is often ordered when someone has experienced unexplained blood clots, recurrent pregnancy loss, or has an underlying autoimmune condition such as lupus. A positive result is typically confirmed with repeat testing weeks later, since transient positives can occur, for example after infection. As with other antiphospholipid markers, this result is one piece of a broader clinical and laboratory picture rather than a stand-alone diagnosis.
Lifestyle factors that influence this marker
- Aim for a balanced, anti-inflammatory eating pattern with plenty of vegetables, fruit, and healthy fats
- Stay physically active with regular moderate exercise to support healthy circulation
- Avoid smoking, which is linked to higher clotting risk
- Prioritize consistent, restorative sleep
- Practice stress-management techniques
- Stay well hydrated, especially during travel or periods of reduced mobility
Tests often checked alongside this
- Cardiolipin Ab IgG — the isotype most strongly linked to clotting risk
- Cardiolipin Ab IgM — another isotype tested in the same panel
- Beta-2-Glycoprotein IgA, IgG, and IgM — related antiphospholipid antibodies
- ANA Pattern and ANA Titer — often checked in suspected lupus overlap
How this can show up in how you look and feel
- May be associated with a history of unexplained blood clots
- May be associated with recurrent pregnancy loss
- May be associated with migraine-like headaches
- May be associated with a mottled skin pattern (livedo reticularis)
What can affect this marker
- Sex
- Pregnancy
- Medications
- Infection
- Lab variability, including the need for repeat confirmatory testing
What to track over time
- Whether a positive result persists on repeat testing weeks later
- How results align with beta-2-glycoprotein antibody and lupus anticoagulant testing
- Whether monitoring is considered before or during pregnancy
What to ask your doctor
- Does this result need to be repeated to confirm a persistent finding?
- How does this relate to my beta-2-glycoprotein antibody results?
- Could this affect pregnancy planning or management?
- Should I be evaluated for antiphospholipid syndrome more broadly?
This glossary entry is for informational purposes only and is not a substitute for professional medical advice. Read our Terms of Use.
References
About our sources
Official sources
Government health agencies, national institutes, and intergovernmental bodies whose guidelines carry regulatory or policy weight.
Clinical / professional
Medical societies, specialty colleges, and professional associations whose consensus statements reflect clinical practice standards.
Peer-reviewed research
Original research articles and systematic reviews published in indexed journals and verified through PubMed or DOI.
